A Study to Assess the Safety, Tolerability and Efficacy of OP0201 as an Adjunct Treatment for Acute Otitis Media in Infants and Children Aged 6 to 24 Months
Condition:   Acute Otitis Media Interventions:   Drug: OP0201 20mg per day+Amoxicillin-clavulanate;   Drug: Placebo 0mg per day+Amoxicillin-clavulanate Sponsor:   Novus Therapeutics, Inc Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 28, 2019 Category: Research Source Type: clinical trials

Necrotizing External Otitis : Retrospective Study in a Regional Bone and Joint Infection Reference Center
Condition:   Bone and Joint Infection Intervention:   Other: necrotizing external otitis Sponsor:   Hospices Civils de Lyon Completed (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - December 7, 2018 Category: Research Source Type: clinical trials